Stock listing

F6T Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: F6T · SWB · EUR · DE

F6T:SWB is the public listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. Based in the United States, Fate Therapeutics focuses on advancing innovative therapies through extensive research and development in regenerative medicine. The company has a market capitalization of approximately €280.9 million, reflecting its position in the biotechnology sector. Recent news and filings may provide insights into its ongoing projects and strategic direction.

F6T:SWBEURDEUpdated July 24, 2026
Fate Therapeutics, Inc. logo
Ticker
F6T:SWB
Asset type
Stock
Market cap
$280.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
SWB
Currency
EUR

Fate Therapeutics, Inc. F6T:SWB stock context

F6T:SWB is the public listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. Based in the United States, Fate Therapeutics focuses on advancing innovative therapies through extensive research and development in regenerative medicine. The company has a market capitalization of approximately €280.9 million, reflecting its position in the biotechnology sector. Recent news and filings may provide insights into its ongoing projects and strategic direction.

Research Fate Therapeutics, Inc.

Alternate listings